Lovenox and Sonata drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Sonata (zaleplon). Common drug interactions include tremor among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Sonata. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Sonata?

Sonata has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 3,330 Sonata users. Check the latest studies of Sonata.



On Jul, 13, 2026

30 people who take Lovenox and Sonata together, and have interactions are studied.

Lovenox and Sonata drug interactions.

What are the common drug interactions of Lovenox and Sonata, by gender? *:

female:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Abdominal pain
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Chest pain
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Emotional distress
  10. Fall

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Vomiting
  6. Anger
  7. Asthenia (weakness)
  8. Cardiac failure congestive
  9. Cough
  10. Diarrhoea

What are the common drug interactions of Lovenox and Sonata, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  3. Hyperglycaemia (high blood sugar)
  4. Type 2 diabetes mellitus
  5. Diabetes mellitus inadequate control
  6. Vision blurred

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Non-small cell lung cancer metastatic (type of epithelial lung cancer spreads to other parts)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Platelet count decreased
  5. Pneumonia
  6. Pneumonia streptococcal (pneumonia, caused by streptococcus pneumoniae)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. White blood cell count increased
  9. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  10. Malignant neoplasm progression (cancer tumour came back)

50-59:

  1. International normalised ratio increased
  2. Death
  3. Jaw disorder (jaw disease)
  4. Tremor (trembling or shaking movements in one or more parts of your body)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Asthenia (weakness)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Cough
  6. Dyslipidaemia (abnormal amount of lipids)
  7. Oropharyngeal pain
  8. Renal failure acute (rapid kidney dysfunction)
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Vision blurred

What are the existing conditions these people have? *

  1. Depression: 7 people, 23.33%
  2. Hiv Infection: 5 people, 16.67%
  3. Cardiac Failure Congestive: 4 people, 13.33%
  4. Pain: 3 people, 10.00%
  5. Nausea (feeling of having an urge to vomit): 3 people, 10.00%
  6. Back Pain: 3 people, 10.00%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  8. Rashes (redness): 2 people, 6.67%
  9. Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 2 people, 6.67%
  10. Otitis Media (inflammation of the middle ear): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Sonata?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovenox and Sonata:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sonata:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sonata and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and zaleplon (the active ingredients of Lovenox and Sonata, respectively), and Lovenox and Sonata (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: